News

Caretaker Medical Unveils VitalStream Roadmap for Streamlined Cardiogenic Shock Monitoring at SCAI 2024

Caretaker Medical, a leading innovator in advanced hemodynamic monitoring solutions, today announced the launch of its VitalStream® Cardiogenic Shock Continuous Monitoring Roadmap at the Society for Cardiovascular Angiography and Interventions (SCAI) 2024 meeting. This roadmap aligns with the National Cardiogenic Shock Initiative[i] criteria and timelines, empowering clinicians with a streamlined approach to early identification, and management of cardiogenic shock (CS).

Cardiogenic shock is a deadly condition where the heart abruptly weakens and cannot pump enough blood to meet the body’s needs. With a mortality rate as high as 50%[ii], early identification is critical for improving patient outcomes. Yet, timely diagnosis of CS remains a challenge.

“The VitalStream Roadmap empowers clinicians to combat this silent killer,” said Jeff Pompeo, CEO of Caretaker Medical. “By simplifying the monitoring process and providing real-time hemodynamic insights within 90 seconds of application, VitalStream can potentially save lives.”

VitalStream: Immediate and Continuous Monitoring for Faster, More Informed Decisions

The VitalStream Roadmap guides clinicians through a standardized process for CS identification using VitalStream, a continuous non-invasive monitoring system. VitalStream offers several key advantages over traditional methods:

  • Rapid Setup: Streamlined application within 90 seconds minimizes time to critical data.
  • Comprehensive Monitoring: Continuously monitors advanced hemodynamics including Blood Pressure (BP), Cardiac Output (CO), Cardiac Power Output (CPO), Heart Rate (HR), Stroke Volume (SV), and Systemic Vascular Resistance (SVR).
  • Dynamic Therapy Response: Provides Delta Values (Delta CO, Delta CPO, Delta MAP, Delta SV, Delta SVR) to enable clinicians to assess a patient’s response to therapy in real-time, guiding ongoing management decisions.

Aligning with National Cardiogenic Shock Initiative

The VitalStream Roadmap is designed to support the goals of the National Cardiogenic Shock Initiative, a program focused on improving CS care through early identification, standardized treatment protocols, and quality improvement measures. By aligning with the Initiative’s criteria and timelines, VitalStream can help hospitals enhance their CS care pathways.

 

Learn more here.

Recent News

05/22/2026

BIO Statement on Veto of Prescription Drug Affordability Boards (PDAB) in VirginiaPatrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription Drug Affordability Board (PDAB) and imposed arbitrary price controls in Virginia. The Governor’s action recognized an important point: even well-intentioned healthcare policies must be carefully designed to avoid unintended consequences for patients, providers, employers, and Virginia’s innovation economy. “BIO is proud to represent biotechnology companies developing the next generation of life-changing medicines, including many in the Commonwealth. We believe policymakers play a critically important role in helping advance both patient access to treatments and the continued growth of the life sciences sector. “We look forward to working with the Governor’s Administration, the General Assembly, Virginia Bio and other stakeholders to advance practical, patient-centered policy solutions that improve affordability while preserving access to care and the innovation ecosystem patients depend on.”

Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription

05/21/2026

Virginia Bio Applauds Governor Spanberger’s Veto of SB 271 and HB 483

The Virginia Biotechnology Association (Virginia Bio) today expressed strong support for Governor Abigail Spanberger’s decision to veto Senate Bill 271 and House Bill 483, legislation that would have established a Prescription Drug Affordability Advisory Panel (PDAAP) in the Commonwealth. Virginia Bio and the Virginia Chamber of Commerce sent a joint letter to Governor Spanberger commending

05/21/2026

New Global Clinical Society to Bring Focused Ultrasound Into Mainstream Medicine

The Focused Ultrasound Foundation today announced the launch of the International Focused Ultrasound Society (IFUS), a new organization dedicated to advancing clinical practice and accelerating adoption of focused ultrasound – a revolutionary, noninvasive therapeutic technology. Established as a program of the Focused Ultrasound Foundation, IFUS aggregates and expands the Foundation’s activities related to clinical implementation